Mimram, L.; Magréault, S.; Kerroumi, Y.; Salmon, D.; Kably, B.; Marmor, S.; Jannot, A.-S.; Jullien, V.; Zeller, V.
Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective Study. Antibiotics 2022, 11, 1462.
https://doi.org/10.3390/antibiotics11111462
AMA Style
Mimram L, Magréault S, Kerroumi Y, Salmon D, Kably B, Marmor S, Jannot A-S, Jullien V, Zeller V.
Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective Study. Antibiotics. 2022; 11(11):1462.
https://doi.org/10.3390/antibiotics11111462
Chicago/Turabian Style
Mimram, Léo, Sophie Magréault, Younes Kerroumi, Dominique Salmon, Benjamin Kably, Simon Marmor, Anne-Sophie Jannot, Vincent Jullien, and Valérie Zeller.
2022. "Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective Study" Antibiotics 11, no. 11: 1462.
https://doi.org/10.3390/antibiotics11111462
APA Style
Mimram, L., Magréault, S., Kerroumi, Y., Salmon, D., Kably, B., Marmor, S., Jannot, A.-S., Jullien, V., & Zeller, V.
(2022). Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective Study. Antibiotics, 11(11), 1462.
https://doi.org/10.3390/antibiotics11111462